Recently, the demand of microphysiological models that will greatly empower clinicians and scientists' capability to examine the function of organs in the laboratory, has generated innovative in vitro 3D tissue models (i.e. organs on chip). However, in order to produce excellent microphysiological analysis platforms, or organs on chip as functional in-vitro organ models or living systems on chip, the convergence of life sciences, engineering, and medicine is the foundation for understanding disease mechanisms and the precision of drug efficacy testing. Numerous multidisciplinary teams are formed for these microphysiological analytic models and have been generating creative activities in microphysiological analytic platforms by integrating precision microengineering and 3D cell culture models, in order to recapitulate microphysiological environments and dynamics. A few excellent groups have demonstrated advanced microfluidic designs to understand complex 3D cellular network behaviors, pathophysiology, the integrated MAPs (iMAPs), or organ on chip. These examples will provide inspiration and groundbreaking solutions for future systems physiology, organogenesis, pathogenesis, or personalized medicine. In this special issue, we recognize the recent progress made in this area. The issue is not only focusd on the review of organs on chip, but also on the progress being made with regards to integrated organs on chip for efficient modeling of pathogenesis, cancer, metabolic syndrome X, neurodegenerative diseases, infectious disease, cardiovascular disease, kidney disease, gastrointestinal tracks (GIs) for enteric disease, skin disease, bone disease, and drug testing towards the realization of a whole www.advancedsciencenews.com www.advhealthmat.de
These excellent examples in this Special Issue by worldleading researchers in the field of organs on chip will provide not only insights into functional microphysiological 3D models for both fundamental life sciences and translational medicine, but also, encouragement to accomplish the mission of reliable in-vitro microphysiological models via multidisciplinary attitude which brings together experts in life sciences, chemistry, physio logy, and engineering. Since the intention of the microphysiological analysis platform is to accomplish quantitative disease analysis and inexpensive drug efficacy testing program for personalized medicine, it is critical to develop extremely reproducible in vitro disease models. As shown in this Special Issue, many groups utilized microengineering for 3D cell culture on chip and primary cells and/or iPSC derived from patients. While we are enjoying examples of organs on chip from these excellent groups' effort, it is a critical time to reflect and find solutions for large-scale production of human cells and precision manufacturing of 3D organs on chip in order to accomplish functional models and the foundation of reliable and predictive toxicity and efficacy assessments of therapeutics.
